Sana Biotechnology, Inc. short interest in 2023
In 2023, Sana Biotechnology, Inc.'s disclosed short interest ran from 13.92% of shares outstanding on 13 Jan 2023 to 11.19% on 29 Dec 2023, a change of -2.73 percentage points. The year's high was 15.86% on 31 Mar 2023 and its low 10.56% on 30 Nov 2023, averaging 13.26% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 39.00 days on 14 Jul 2023. Full history: Sana Biotechnology, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 13.92% (13 Jan 2023)
- End of year
- 11.19% (29 Dec 2023)
- Change
- -2.73 pp
- High
- 15.86% (31 Mar 2023)
- Low
- 10.56% (30 Nov 2023)
- Average
- 13.26%
- Highest days to cover
- 39.00 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 13.92% | 24.73 | |
| 31 Jan 2023 | 13.63% | 27.57 | |
| 15 Feb 2023 | 14.15% | 33.51 | |
| 28 Feb 2023 | 14.60% | 27.72 | |
| 15 Mar 2023 | 15.68% | 28.75 | |
| 31 Mar 2023 | 15.86% | 30.61 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 15.44% | 17.18 | |
| 28 Apr 2023 | 14.75% | 21.61 | |
| 15 May 2023 | 14.76% | 17.95 | 10-Q filed, results (8-K) |
| 31 May 2023 | 14.78% | 18.02 | |
| 15 Jun 2023 | 14.36% | 23.59 | |
| 30 Jun 2023 | 14.54% | 17.01 | |
| 14 Jul 2023 | 14.33% | 39.00 | |
| 31 Jul 2023 | 11.93% | 22.96 | |
| 15 Aug 2023 | 11.82% | 28.40 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 11.89% | 36.76 | |
| 15 Sep 2023 | 11.46% | 19.05 | |
| 29 Sep 2023 | 12.42% | 20.90 | |
| 13 Oct 2023 | 13.10% | 17.98 | |
| 31 Oct 2023 | 11.35% | 16.09 | |
| 15 Nov 2023 | 10.96% | 14.32 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 10.56% | 17.23 | |
| 15 Dec 2023 | 10.77% | 12.79 | |
| 29 Dec 2023 | 11.19% | 15.01 |
See also: Sana Biotechnology, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.